|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7048 | (2006.01) |
| A61P 3/10 | (2006.01) | ||
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 2981271 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14715578.2 |
| Date of filing the European patent application | 2014-04-03 | |
| (97) | Date of publication of the European application | 2016-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (86) | Number | PCT/EP2014/056657 |
| Date | 2014-04-03 |
| (87) | Number | WO 2014/161919 |
| Date | 2014-10-09 |
| (30) | Number | Date | Country code |
| 201361808804 P | 2013-04-05 | US | |
| 2812519 | 2013-04-10 | CA | |
| 201361908991 P | 2013-11-26 | US |
| (72) |
BROEDL, Uli, DE
VON EYNATTEN, Maximilian, DE
MACHA,Sreeraj, US
WOERLE, Hans-Juergen, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Empagliflozino terapinis panaudojimas |
| THERAPEUTIC USES OF EMPAGLIFLOZIN |
| Payment date | Validity (years) | Amount | |
| 2025-03-24 | 12 | 289.00 EUR |
| 2026-04-03 |